by Claudia Li | Oct 6, 2020 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ October ❯ FDA Report: DiaCarta COVID-19 Tests Rank Top 3 Among FDA SARS-CoV-2 Reference Panel Tests FollowFollow Richmond, California, September 21, 2020. According to the recent FDA...
by Claudia Li | Jul 15, 2020 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ category ❯ Press Releases ❯ DiaCarta Receives Regulatory COFEPRIS Approval in Mexico & ICMR Approval in India for its FDA EUA Approved QuantiVirus™ SARS-CoV-2 Test FollowFollow Richmond,...
by Claudia Li | Mar 25, 2020 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ category ❯ Press Releases ❯ DiaCarta Inc. has filed for EUA with the FDA and has received CE mark for its highly sensitive QuantiVirus™ SARS-CoV-2 Test Kit FollowFollow Richmond, California, March...
by Claudia Li | Apr 13, 2020 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Search ❯ 65 GEN ❯ DiaCarta SARS-CoV-2 Test Detecting 3 Viral Genes Receives US FDA Emergency Use Authorization & Test Manufacturing Expanded to 500K COVID-19 Tests/Week FollowFollow Richmond,...
by DiaCarta Inc. | Jan 17, 2019 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ January ❯ CIO Bulletin Announces DiaCarta Inc. As One of the 30 Fastest Growing Companies of 2018 FollowFollow RICHMOND, Calif.–(BUSINESS WIRE)–DiaCarta today announced that...
by DiaCarta Inc. | Oct 29, 2018 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ category ❯ Press Releases ❯ DiaCarta Inc. Launches Ultra-Sensitive TaqMan-Based qPCR Assays for Cancer Gene Mutation Detection FollowFollow DIACARTA Inc., a precision molecular diagnostics company...